Guardant Health Investor Presentation
Digital sequencing platform
Patented proprietary technology for unlocking cancer's signals from blood
GUARDANT DIGITAL SEQUENCING PLATFORM
High-
Efficiency
Chemistry
Next
Generation
Sequencing
T»
Learning
Bioinformatics
Engine
TCAGCATTAGCTAGTGCGCTA
AGOTAGCTAGCTAGTGCATG
GCATCGCA
Biochemistry
Genomic
sequencing
Signal
processing
LUNAR-2
LUNAR - 1
GUARDANT OMNI
TM
GUARDANT 360"
REPORTING
PHYSICIAN
Adde
310 Fax
Summary of Somatic Aburation & Assosiated Treatment Options
COPY TOM
ar
EGFREE A7500
ExonDeletor
%COMA.or
Associated
FDA haples
Own
224
N
Cara avalability
Erin Cink, M
Yes Neatry
Yes None Naty
EML4-ALK Fusion
AGGAGTGTG
COWD A
Median
Pack
C
Bioinformatics
Process engineering
Machine learning
60+ PATENTS ISSUED AND 130+ PENDING PATENT APPLICATIONS
P
Now
yoy
Vee More Newly
Vee None N
We evaluated 73 ganes, including the following guidline-recommended genes for NSCLC:
ALX
ME
RET
7
GUARDANT™View entire presentation